111 related articles for article (PubMed ID: 6774044)
1. HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.
Kaufman JF; Andersen RL; Strominger JL
J Exp Med; 1980 Aug; 152(2 Pt 2):37s-53s. PubMed ID: 6774044
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
3. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
4. Human B cell alloantigens; alpha subunit variability.
Markert ML; Cresswell P
J Immunol; 1982 May; 128(5):1999-2003. PubMed ID: 6977579
[TBL] [Abstract][Full Text] [Related]
5. Separation of three class II antigens from a homozygous human B cell line.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant.
Taketani S; Krangel MS; Pious D; Strominger JL
J Immunol; 1983 Dec; 131(6):2935-8. PubMed ID: 6196407
[TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of the polymorphism of three HLA-D region antigens.
de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
Lloyd KO; Ng J; Dippold WG
J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of structural polymorphism among MB3 light chains by two-dimensional gel electrophoresis.
Ishikawa N; Kasahara M; Ikeda H; Ogasawara K; Hawkin S; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
J Immunol; 1985 Jan; 134(1):417-22. PubMed ID: 3871113
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
Shackelford DA; Strominger JL
J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
[TBL] [Abstract][Full Text] [Related]
11. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
12. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
13. Cell-free synthesis and processing of the heavy and light chains of HLA-DR antigens.
Korman AJ; Ploegh HL; Kaufman JF; Owen MJ; Strominger JL
J Exp Med; 1980 Aug; 152(2 Pt 2):65s-82s. PubMed ID: 6967942
[TBL] [Abstract][Full Text] [Related]
14. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
15. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of Ia alloantigens in guinea pigs. II. Comparative peptide mapping of Ia antigens from B cells, T cells, and macrophages.
Lyons CR; Cook RG; Tucker TF; Uhr JW
J Immunol; 1981 Nov; 127(5):1885-8. PubMed ID: 6975302
[TBL] [Abstract][Full Text] [Related]
17. [Primary structure of human class II histocompatibility antigens (HLA-D). II. Separation of alpha from beta-chains of HLA-D from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2,2;MT1,1;DC1,1;MB1,1), and characterization of the isolated chain].
Egert G; Thinnes FP; Götz H; Pauly E; Kratzin H; Yang CY; Kölbel S; Altevogt P; Wernet P; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1291-308. PubMed ID: 6334639
[TBL] [Abstract][Full Text] [Related]
18. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
[TBL] [Abstract][Full Text] [Related]
20. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
